R
Rocket Pharmaceuticals, Inc.
RCKT · NASDAQ · Healthcare · 379M
Closing price
$2.56
-2.66% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.0×
Enterprise value / EBITDAEV/EBITDA
-1.1×
Free cash flow yieldFCF yield
-66.9%
Return on equityROE
-80.5%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
-120.8×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.